Dermatology is undergoing a fundamental shift from treating skin conditions through trial-and-error to using personalized medicine, where doctors match patients with treatments specifically suited to their individual biology and disease characteristics. This precision approach aims to deliver the right treatment to the right patient at the right time, moving away from the traditional model where patients might cycle through multiple medications before finding one that works .

What Is Personalized Medicine in Dermatology?

Personalized medicine in dermatology represents a move toward stratified and precision approaches that consider each patient's unique characteristics, disease profile, and biological markers. Rather than prescribing the same treatment to everyone with a given skin condition, dermatologists now use patient data and scientific insights to predict which treatments will be most effective for each individual. This approach is particularly transforming care for chronic conditions like psoriasis and hidradenitis suppurativa, a painful inflammatory skin disease .

The shift reflects a broader recognition that skin diseases are not one-size-fits-all conditions. Two patients with psoriasis, for example, may have entirely different underlying biological drivers, which means they may respond very differently to the same medication. By identifying these differences upfront, doctors can avoid months of ineffective treatment and get patients to remission faster.

How Are Dermatologists Implementing Precision Treatment Strategies?

• Biomarker Testing: Doctors identify specific biological markers in patients' blood or skin that predict which medications will work best, allowing them to skip ineffective treatments and move directly to therapies with the highest success rate.
• Disease Stratification: Patients are grouped based on disease severity, type, and underlying cause rather than receiving identical treatment protocols, ensuring that mild cases receive proportionate care while severe cases get aggressive intervention.
• Treatment Matching: Dermatologists use patient data to match individuals with targeted therapies designed to address their specific disease mechanism, reducing the trial-and-error cycle that historically characterized skin disease management.

According to experts leading this transformation, the conversation in dermatology is fundamentally changing. Instead of asking "What medication should we try next?" doctors are now asking "What does this patient's disease look like at the molecular level, and which treatment is designed to address that specific problem?" .

What Challenges Does Personalized Medicine Face in Dermatology?

While the scientific promise of personalized medicine is clear, real-world implementation faces significant hurdles. Cost remains a major barrier; biomarker testing and precision diagnostics can be expensive, and not all healthcare systems or insurance plans cover these services. Accessibility is another critical concern, as personalized approaches require specialized expertise and infrastructure that may not be available in all regions or communities .

Health equity represents perhaps the most pressing ethical challenge. If personalized medicine becomes available only to wealthy patients or those in well-resourced healthcare systems, it could widen existing disparities in skin disease outcomes. Experts emphasize that for personalized medicine to truly transform dermatology, these approaches must be made accessible and affordable across all patient populations, regardless of socioeconomic status or geographic location .

The conversation around personalized medicine in dermatology also includes practical questions about implementation. How will dermatologists integrate biomarker testing into routine clinical practice? How can healthcare systems afford to adopt these approaches? What training will clinicians need to interpret and act on precision medicine data? These questions are being actively discussed among dermatology leaders as the field moves forward .

How Will Personalized Medicine Change Everyday Dermatology Care?

For patients, the implications are significant. Instead of spending months trying different treatments, many people with chronic skin conditions could receive effective therapy much faster. For dermatologists, personalized medicine means moving from a reactive, trial-and-error approach to a proactive, data-driven one. This shift requires not just new technology but also a change in clinical mindset and practice patterns .

The transformation is already beginning in specialized centers and academic dermatology programs, where researchers and clinicians are developing and testing precision approaches. As these methods become more standardized and accessible, they are expected to reshape how dermatologists approach conditions ranging from psoriasis to hidradenitis suppurativa and beyond. The goal is clear: better outcomes for patients, fewer wasted treatment attempts, and a healthcare system that respects the biological reality that every patient's skin disease is unique.

"Personalised medicine is reshaping dermatology scientifically, clinically, and ethically, and what it means for everyday patient care," noted the experts leading the discussion on this transformation.

Prof. Jo Lambert and Prof. Curdin Conrad, Guest Editors, JEADV Special Issue on Personalised Medicine

The European Academy of Dermatology and Venereology (EADV) recently dedicated a special issue of its journal to personalized medicine in dermatology, bringing together leading researchers and clinicians to explore how this approach can be implemented responsibly and equitably. The conversation reflects a profession committed to moving beyond one-size-fits-all treatment toward a future where every patient receives care tailored to their individual needs .